Agnes C Cheruiyot
Overview
Explore the profile of Agnes C Cheruiyot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okore W, Ouma C, Okoth R, Yeda R, Ingasia L, Mwakio E, et al.
PLoS One
. 2024 Jun;
19(6):e0298585.
PMID: 38900782
Single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum multi-drug resistance protein 1 (Pfmrp1) gene have previously been reported to confer resistance to Artemisinin-based Combination Therapies (ACTs) in Southeast Asia. A...
2.
Muema J, Mutunga J, Obonyo M, Getahun M, Mwakubambanya R, Akala H, et al.
Malar J
. 2023 May;
22(1):161.
PMID: 37208735
Background: The unmet demand for effective malaria transmission-blocking agents targeting the transmissible stages of Plasmodium necessitates intensive discovery efforts. In this study, a bioactive bisbenzylisoquinoline (BBIQ), isoliensinine, from Cissampelos pariera...
3.
Chemwor G, Andagalu B, Onyango I, Opot B, Okoth R, Yedah R, et al.
Int J Infect Dis
. 2023 Apr;
132:17-25.
PMID: 37061211
Objectives: This study examined the treatment response of mixed vs single-species Plasmodium falciparum infections to artemisinin-based combination therapies (ACTs). Methods: A total of 1211 blood samples collected on days 0,...
4.
Wakoli D, Ondigo B, Ochora D, Amwoma J, Okore W, Mwakio E, et al.
BMC Med
. 2022 Nov;
20(1):448.
PMID: 36397090
Background: Dihydroartemisinin-piperaquine (DHA-PPQ) is an alternative first-line antimalarial to artemether-lumefantrine in Kenya. However, recent reports on the emergence of PPQ resistance in Southeast Asia threaten its continued use in Kenya...
5.
Yeda R, Okudo C, Owiti E, Biwot G, Momanyi C, Korir W, et al.
Malar J
. 2022 Sep;
21(1):251.
PMID: 36050680
Background: The ABO blood groups consist of A, B, and H carbohydrate antigens, which regulate protein activities during malaria infection in humans. Understanding the interplay between the malaria parasite and...
6.
Mutisya J, Mobegi V, Kinyua J, Kivecu M, Okoth R, Chemwor G, et al.
F1000Res
. 2022 May;
9:1268.
PMID: 35600144
The emergence of artemisinin resistance in South East Asia calls for urgent discovery of new drug compounds that have antiplasmodial activity. Unlike the classical compound screening drug discovery methods, the...
7.
Akala H, Watson O, Mitei K, Juma D, Verity R, Ingasia L, et al.
Lancet Microbe
. 2022 May;
2(4):e141-e150.
PMID: 35544189
Background: The epidemiology and severity of non-falciparum malaria in endemic settings has garnered little attention. We aimed to characterise the prevalence, interaction, clinical risk factors, and temporal trends of non-falciparum...
8.
Ochora D, Kakudidi E, Namukobe J, Ipulet P, Wakoli D, Okore W, et al.
Plants (Basel)
. 2022 Jan;
11(1).
PMID: 35009051
Malaria is the most lethal parasitic disease in the world. The frequent emergence of resistance by malaria parasites to any drug is the hallmark of sustained malaria burden. Since the...
9.
Mogire R, Akala H, Macharia R, Juma D, Cheruiyot A, Andagalu B, et al.
PLoS One
. 2017 Nov;
12(10):e0186364.
PMID: 29088219
Malaria causes about half a million deaths annually, with Plasmodium falciparum being responsible for 90% of all the cases. Recent reports on artemisinin resistance in Southeast Asia warrant urgent discovery...
10.
Muiva-Mutisya L, Atilaw Y, Heydenreich M, Koch A, Akala H, Cheruiyot A, et al.
Nat Prod Res
. 2017 Jul;
32(12):1407-1414.
PMID: 28714338
The CHCl/MeOH (1:1) extract of the aerial parts of Tephrosia subtriflora afforded a new flavanonol, named subtriflavanonol (1), along with the known flavanone spinoflavanone B, and the known flavanonols MS-II...